featured
CRISPR-Cas9 Gene Editing With Nexiguran Ziclumeran in Patients With ATTR Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
N. Engl. J. Med 2024 Nov 16;[EPub Ahead of Print], M Fontana, SD Solomon, J Kachadourian, L Walsh, R Rocha, D Lebwohl, D Smith, J Täubel, EJ Gane, B Pilebro, D Adams, Y Razvi, J Olbertz, A Haagensen, P Zhu, Y Xu, A Leung, A Sonderfan, DE Gutstein, JD GillmoreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.